CYNVEC
Cynvec, an early stage biotech company based in New York City, was created in 2004 through the spin out of exclusively licensed IP from New York University focusing on the utility of the sindbis oncolytic viral vector in the treatment of cancer. It is based on the work of Dr. Daniel Meruelo, Ph.D., the world's leading authority on the virus and professor at NYU. Cynvec is in the process of preparing an investigational new drug application (IND) for our first product, CYN 101.
CYNVEC
Industry:
Biotechnology Health Care Medical
Founded:
2004-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.cynvec.com
Total Employee:
1+
Status:
Active
Contact:
+1 (732) 492.1797
Email Addresses:
[email protected]
Total Funding:
2.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins
Current Employees Featured
Founder
Official Site Inspections
http://www.cynvec.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: 104.0.153.160.host.secureserver.net
- IP address: 160.153.0.104
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
Loading ... 